Nephrogenex Inc (NRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | NRX | CYTO | SLRX | ||
Company | Nephrogenex Inc | Altamira Therapeutics Ltd | Salarius Pharmaceuticals Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 0.12 | 1.1500 | 1.7300 | ||
High | 0.16 | 1.1500 | 1.7300 | ||
Low | 0.12 | 1.1500 | 1.7300 | ||
Last | 0.14 | 1.1500 | 1.7300 | ||
Change | +0.01 | -0.0500 | -0.1000 | ||
% Change | +7.69% | -4.17% | -5.46% | ||
Volume | 822,900 | 45,915 | 22,928 | ||
20-Day Average Volume | 663,825 | 282,871 | 1,348,506 | ||
Previous Close | 0.13 | 1.2000 | 1.8300 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | No | No | ||
Technicals | |||||
20-Day Moving Average | 0.35 | 1.2337 | 2.2076 | ||
20-Day Raw Stochastic | 5.13% | 20.82% | 23.31% | ||
20-Day Relative Strength | 33.39% | 41.36% | 38.08% | ||
Weighted Alpha | -91.19 | -83.74 | -78.74 | ||
Today's Opinion | N/A | 100% Sell | 100% Sell | ||
Previous Opinion | N/A | 100% Sell | 100% Sell | ||
Last Month's Opinion | N/A | 100% Sell | 100% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | unch since 05/03/16 | -14.81% since 07/15/24 | -2.81% since 07/15/24 | ||
Low | 0.10 on 05/09/16 | 1.0800 on 07/19/24 | 1.3500 on 07/16/24 | ||
High | 0.19 on 05/05/16 | 1.5300 on 07/19/24 | 2.9200 on 07/18/24 | ||
1-Month | |||||
%Chg | -70.21% since 04/08/16 | +2.68% since 06/21/24 | -31.35% since 06/21/24 | ||
Low | 0.10 on 05/09/16 | 1.0501 on 06/25/24 | 1.3500 on 07/16/24 | ||
High | 0.88 on 04/26/16 | 1.5300 on 07/19/24 | 2.9800 on 06/25/24 | ||
3-Month | |||||
%Chg | -85.26% since 02/10/16 | -17.86% since 04/22/24 | -57.75% since 04/22/24 | ||
Low | 0.10 on 05/09/16 | 1.0501 on 06/25/24 | 1.3500 on 07/16/24 | ||
High | 1.20 on 02/22/16 | 2.4699 on 05/23/24 | 4.3456 on 05/01/24 | ||
6-Month | |||||
%Chg | -93.94% since 11/10/15 | -48.89% since 01/22/24 | -60.32% since 01/22/24 | ||
Low | 0.10 on 05/09/16 | 1.0501 on 06/25/24 | 1.3500 on 07/16/24 | ||
High | 2.85 on 12/14/15 | 3.4900 on 03/25/24 | 6.3104 on 03/01/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 1,680 | 1,893 | 1,093 | ||
Shares Outstanding, K | 12,950 | 1,578 | 597 | ||
Annual Sales | 0 | 0 | 0 | ||
Annual Net Income | -22,860,000 | -4,310,000 | -12,540,000 | ||
Last Quarter Sales | N/A | 0 | 0 | ||
Last Quarter Net Income | N/A | -3,690,866 | -1,720,000 | ||
60-Month Beta | 0.57 | 1.80 | 0.92 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | N/A | -3.28 on 05/13/24 | ||
Latest Earnings Date | 05/11/16 | 07/10/24 | 08/08/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |